Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BMS extends deal with Samsung as its pipeline percolates with more biologics
Fierce Pharma
Friday, April 25, 2014 - 9:08am
tags:
Bristol-Myers Squibb, Samsung BioLogics
Sarepta's Still a Gamble, Even With FDA Reversal
Motley Fool
Friday, April 25, 2014 - 8:31am
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Emergent's BioThrax Gets Orphan Drug Status
Yahoo/Zacks.com
Friday, April 25, 2014 - 8:27am
tags:
Emergent BioSolutions, BioThrax, orphan drugs, anthrax, vaccines
Cytokinetics says Lou Gehrig's drug fails mid-stage trial
Yahoo/Reuters
Friday, April 25, 2014 - 8:22am
tags:
Lou Gehrig's disease, Cytokinetics, ALS, Tirasemtiv
AbbVie shares rise after earnings top forecasts
Marketwatch
Friday, April 25, 2014 - 8:18am
tags:
AbbVie, earnings
Best Weapon In The War On Cancer? Data Sharing
Forbes
Friday, April 25, 2014 - 8:18am
tags:
data sharing, clinical trials, cancer, oncology, Project Data Sphere
Novartis INSTEAD study for Onbrez Breezhaler meets primary objective
Yahoo/Fly on the Wall
Friday, April 25, 2014 - 8:14am
tags:
Novartis, Onbrez Breezhaler, COPD
Prestige Brands to buy Insight Pharma for $750 million
Marketwatch
Friday, April 25, 2014 - 8:13am
tags:
Prestige Brands, M&A, Insight Pharma
Alexion Posts Strong Earnings in Q1
Yahoo/Zacks.com
Thursday, April 24, 2014 - 5:58pm
tags:
Alexion, earnings
FDA approves Roche HPV DNA test for primary cervical cancer screening
Yahoo/Fly on the Wall
Thursday, April 24, 2014 - 5:56pm
tags:
FDA, Roche, DNA, cervical cancer, HPV, cobas HPV test
UCB Sales Rise in Q1
Yahoo/Zacks.com
Thursday, April 24, 2014 - 5:55pm
tags:
UCB Pharmaceuticals, earnings
Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
First Word Pharma
Thursday, April 24, 2014 - 11:36am
tags:
Celgene, Nogra Pharma, Crohn's Disease, GED-0301
Allergan sales force key to Valeant chief's plans for post-merger growth
Fierce Pharma Marketing
Thursday, April 24, 2014 - 11:32am
tags:
Allergan, Valeant Pharmaceuticals, drug reps, M&A
Pfizer concedes Celebrex to Actavis, Teva after 2015 patent strike-down
Fierce Pharma
Thursday, April 24, 2014 - 11:30am
tags:
patents, Celebrex, Teva Pharmaceuticals, Actavis, generics
Celgene profit down but tops expectations; keeps forecast
Yahoo/Reuters
Thursday, April 24, 2014 - 11:26am
tags:
Celgene, earnings
AstraZeneca flags cancer advances, silent on Pfizer bid talk
Yahoo/Reuters
Thursday, April 24, 2014 - 11:23am
tags:
Pfizer, AstraZeneca, M&A, cancer, earnings
[video]Is This Struggling Drugmaker Worth $100 Billion?
Motley Fool
Thursday, April 24, 2014 - 9:52am
tags:
Pfizer, M&A, AstraZeneca
Orthopedic device maker Zimmer buying Biomet in cash-and-stock deal valued at about $13.35B
Yahoo/AP
Thursday, April 24, 2014 - 9:46am
tags:
devices, Zimmer, Biomet
GSK's R&D staff hit with trade rumors spurred by Novartis' cancer pact
Fierce Biotech
Thursday, April 24, 2014 - 8:22am
tags:
GSK, R&D, Novartis, M&A
Zogenix Announces Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International
Yahoo
Thursday, April 24, 2014 - 8:13am
tags:
Zogenix, Sumavel DosePro, migraines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.